SCHEMBL4063237

SCHEMBL4063237

CCO[Si](C)(CCCCN1CCNCC1)OCC

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 2/20 0.43
GNAO1 P09471 5/20 0.37
GNAI3 P08754 4/20 0.37
GNAI1 P63096 4/20 0.37
SOD3 P08294 2/20 0.36
SIGMAR1 Q99720 2/20 0.36
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
RAB9A P51151 1/20 0.35
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL774670 0.95 CXCR4 (0.42) CXCR4GNAO1GNAI3GNAI1SOD3
SCHEMBL4063799 0.88 SIGMAR1 (0.37) CXCR4SIGMAR1POLBSMN1; SMN2HSD17B10
SCHEMBL31687741 0.87 CXCR4 (0.39) CXCR4GNAO1GNAI3GNAI1SOD3
SCHEMBL4065759 0.87 CXCR4 (0.43) CXCR4GNAO1GNAI3GNAI1SOD3
SCHEMBL4063582 0.85 CXCR4 (0.44) CXCR4GNAO1GNAI3GNAI1SOD3
SCHEMBL28769738 0.84 CXCR4 (0.37) CXCR4GNAO1GNAI3GNAI1SOD3
SCHEMBL31265242 0.83 CYP3A4 (0.40) CXCR4SIGMAR1KDM4EALDH1A1POLB
SCHEMBL4067154 0.83 CXCR4 (0.46) CXCR4GNAO1GNAI3GNAI1SOD3
SCHEMBL11655734 0.82 CXCR4 (0.40) CXCR4GNAO1GNAI3GNAI1SOD3
SCHEMBL4063049 0.81 CXCR4 (0.42) CXCR4GNAO1GNAI3GNAI1SOD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7569691-B2 Protected piperazino group-bearing organoxysilane compound and making method SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-08-04 US claimed
US-7569691-B2 Protected piperazino group-bearing organoxysilane compound and making method SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-08-04 US disclosed
EP-1714968-B1 Protected piperazino group-bearing organoxysilane compound and making method SHINETSU CHEMICAL CO (JP) 2008-07-16 EP disclosed
US-20060241294-A1 Protected piperazino group-bearing organoxysilane compound and making method SHIN-ETSU CHEMICAL CO., LTD. 2006-10-26 US disclosed
EP-1714968-A1 Protected piperazino group-bearing organoxysilane compound and making method Shin-Etsu Chemical Co., Ltd. (JP) 2006-10-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241294-A1 Protected piperazino group-bearing organoxysilane compound and making method PIEZO1, VCL, VIM CXCR4 3143/4885GNAO1 646/4885GNAI3 2419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.